Organon & Co. (OGN)
Organon & Statistics
Share Statistics
Organon & has 257.95M shares outstanding. The number of shares has increased by 0.3% in one year.
| Shares Outstanding | 257.95M |
| Shares Change (YoY) | 0.3% |
| Shares Change (QoQ) | 0.16% |
| Owned by Institutions (%) | 80.07% |
| Shares Floating | 257.08M |
| Failed to Deliver (FTD) Shares | 11 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 15.13M, so 5.88% of the outstanding shares have been sold short.
| Short Interest | 15.13M |
| Short % of Shares Out | 5.88% |
| Short % of Float | 7.84% |
| Short Ratio (days to cover) | 3.45 |
Valuation Ratios
The PE ratio is 4.44 and the forward PE ratio is 2.76. Organon &'s PEG ratio is -0.27.
| PE Ratio | 4.44 |
| Forward PE | 2.76 |
| PS Ratio | 0.6 |
| Forward PS | 0.4 |
| PB Ratio | 8.13 |
| P/FCF Ratio | 5.02 |
| PEG Ratio | -0.27 |
Enterprise Valuation
Organon & has an Enterprise Value (EV) of 12.04B.
| EV / Sales | 1.88 |
| EV / EBITDA | 7.51 |
| EV / EBIT | 12.82 |
| EV / FCF | 15.76 |
Financial Position
The company has a current ratio of 1.6, with a Debt / Equity ratio of 18.81.
| Current Ratio | 1.6 |
| Quick Ratio | 1.11 |
| Debt / Equity | 18.81 |
| Debt / EBITDA | 5.54 |
| Debt / FCF | 11.62 |
| Interest Coverage | 2.86 |
Financial Efficiency
Return on Equity is 183.05% and Return on Invested Capital is 15.29%.
| Return on Equity | 183.05% |
| Return on Assets | 6.59% |
| Return on Invested Capital | 15.29% |
| Revenue Per Employee | $640.3K |
| Profits Per Employee | $86.4K |
| Employee Count | 10,000 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.03 |
Taxes
| Income Tax | -57M |
| Effective Tax Rate | -7.06% |
Stock Price Statistics
The stock price has increased by -37.74% in the last 52 weeks. The beta is 0.69, so Organon &'s price volatility has been higher than the market average.
| Beta | 0.69 |
| 52-Week Price Change | -37.74% |
| 50-Day Moving Average | 14.43 |
| 200-Day Moving Average | 17.16 |
| Relative Strength Index (RSI) | 31.91 |
| Average Volume (20 Days) | 3.62M |
Income Statement
In the last 12 months, Organon & had revenue of 6.4B and earned 864M in profits. Earnings per share was 3.36.
| Revenue | 6.4B |
| Gross Profit | 3.71B |
| Operating Income | 1.49B |
| Net Income | 864M |
| EBITDA | 1.6B |
| EBIT | 1.33B |
| Earnings Per Share (EPS) | 3.36 |
Balance Sheet
The company has 675M in cash and 8.88B in debt, giving a net cash position of -8.21B.
| Cash & Cash Equivalents | 675M |
| Total Debt | 8.88B |
| Net Cash | -8.21B |
| Retained Earnings | 1.01B |
| Total Assets | 13.1B |
| Working Capital | 1.63B |
Cash Flow
In the last 12 months, operating cash flow was 939M and capital expenditures -175M, giving a free cash flow of 764M.
| Operating Cash Flow | 939M |
| Capital Expenditures | -175M |
| Free Cash Flow | 764M |
| FCF Per Share | 2.97 |
Margins
Gross margin is 58.02%, with operating and profit margins of 23.21% and 13.49%.
| Gross Margin | 58.02% |
| Operating Margin | 23.21% |
| Pretax Margin | 12.6% |
| Profit Margin | 13.49% |
| EBITDA Margin | 25.05% |
| EBIT Margin | 23.21% |
| FCF Margin | 11.93% |
Dividends & Yields
OGN pays an annual dividend of $1.4, which amounts to a dividend yield of 7.43%.
| Dividend Per Share | $1.40 |
| Dividend Yield | 7.43% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 42.04% |
| Earnings Yield | 22.53% |
| FCF Yield | 19.92% |
Analyst Forecast
The average price target for OGN is $20, which is 79.9% higher than the current price. The consensus rating is "Hold".
| Price Target | $20 |
| Price Target Difference | 79.9% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
Scores
| Altman Z-Score | 1.23 |
| Piotroski F-Score | 5 |